Abstract
American Journal of HematologyVolume 53, Issue 3 p. 204-205 Letters and CorrespondenceFree Access Gancyclovir-induced megakaryocyte loss in chronic myelogenous leukemia post bone-marrow transplant Laura Gardner, Corresponding Author Laura Gardner Department of Pathology, St. Louis University Medical Center, St. Louis, MissouriDepartment of Pathology, St. Louis University Medical Center, St. Louis, MissouriSearch for more papers by this authorLeonard E. Grosso, Leonard E. Grosso Department of Pathology, St. Louis University Medical Center, St. Louis, MissouriSearch for more papers by this author Laura Gardner, Corresponding Author Laura Gardner Department of Pathology, St. Louis University Medical Center, St. Louis, MissouriDepartment of Pathology, St. Louis University Medical Center, St. Louis, MissouriSearch for more papers by this authorLeonard E. Grosso, Leonard E. Grosso Department of Pathology, St. Louis University Medical Center, St. Louis, MissouriSearch for more papers by this author First published: November 1996 https://doi.org/10.1002/(SICI)1096-8652(199611)53:3<204::AID-AJH13>3.0.CO;2-DAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1 Hopt UT, Pfeffer F, Schareck W, Busing M, Ming C: Gancyclovir for prophylaxis of CMV disease after pancreas/kidney transplantation. Transplant Proc 26: 434, 1994. 2 Goodrich JM, Motomi M, Gleaves C, DuMond C, Cays M, Ebeling DF, Buhles WD, DeArmond B, Meyers JD: Early treatment with gancyclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation. N Engl J Med 325: 1601, 1991. 3 Atkinson K, Downs K, Golenia M, Biggs J, Marshall G, Dodds A, Concannon A: Prophylactic use of gancyclovir in allogeneic bone marrow transplantation: Absence of clinical cytomegalovirus infection. Br J Haematol 79: 57, 1991. 4 DeArmond B: Safety considerations in the use of gancyclovir in immunocompromised patients. Transplant Proc 23: 26, 1991. 5 Beris P, Mieschen PA: Hematological complications of anti-infectious agents. Semin Hematol 25: 123, 1988. Volume53, Issue3November 1996Pages 204-205 ReferencesRelatedInformation
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
